iECURE is a Biotech company based in Philadelphia, Pennsylvania. It has raised $50M in total funding. Latest round: Series A.
iECURE funding overview
iECURE is a Biotech company based in Philadelphia, Pennsylvania. iECURE has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for iECURE runs through 2021; nothing later has been disclosed. Investors on record include Versant Ventures, OrbiMed Advisors. 2 distinct backers are named across the disclosed rounds.
iECURE at a glance
Total raised
$50M
Latest round
Series A
Latest round date
September 2021
Industry
Biotech
Headquarters
Philadelphia, Pennsylvania
Notable investors
Versant Ventures, OrbiMed Advisors
Frequently asked about iECURE funding
How much has iECURE raised?
iECURE has raised $50M in total disclosed funding across the rounds on record.
Who has invested in iECURE?
Versant Ventures, OrbiMed Advisors are named among the investors backing iECURE.
What was the latest iECURE funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is iECURE based?
iECURE is based in Philadelphia, Pennsylvania.
What sector does iECURE operate in?
iECURE is tracked under Biotech from Philadelphia, Pennsylvania, with $50M in disclosed funding.
When did iECURE last raise?
The last disclosed iECURE round closed in September 2021 at Series A.
Totals shown for iECURE aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Philadelphia and the investors behind them below.
